Stroke and Vascular Neurology
-
Publication Venue For
- Initial antihypertensive agent effects on acute blood pressure after intracerebral haemorrhage.. 7:367-374. 2022
- Rationale and design of a stepped wedge cluster randomised trial to improve acute reperfusion treatment quality for stroke: IMPROVE stroke care in China.. 7:451-456. 2022
- Temporal trends and rural-urban disparities in cerebrovascular risk factors, in-hospital management and outcomes in ischaemic strokes in China from 2005 to 2015: a nationwide serial cross-sectional survey. 2022
- LDL-C levels, lipid-lowering treatment and recurrent stroke in minor ischaemic stroke or TIA.. 7:276-284. 2022
- Functional status at 30 and 90 days after mild ischaemic stroke.. 7:375-380. 2022
- Patterns of antidepressant therapy and clinical outcomes among ischaemic stroke survivors.. 6:384-394. 2021
- Outcomes of Medicare beneficiaries hospitalised with transient ischaemic attack and stratification using the ABCD2 score.. 6:314-318. 2021
- Implementation of regional Acute Stroke Care Map increases thrombolysis rates for acute ischaemic stroke in Chinese urban area in only 3 months.. 6:87-94. 2021
- Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study.. 5:279-284. 2020
- Emergency medical services use and its association with acute ischaemic stroke evaluation and treatment in Singapore.. 5:121-127. 2020
- Acute ischaemic stroke interventions: large vessel occlusion and beyond.. 5:80-85. 2020
- Stroke mechanisms and outcomes of isolated symptomatic basilar artery stenosis.. 4:189-197. 2019
- Rationale and design of Patient-centered Retrospective Observation of Guideline-Recommended Execution for Stroke Sufferers in China: China PROGRESS.. 4:165-170. 2019
- Safety of tirofiban and dual antiplatelet therapy in treating intracranial aneurysms.. 4:36-42. 2019
- Apolipoprotein E mimetic peptide CN-105 improves outcome in a murine model of SAH.. 3:222-230. 2018
- Chinese Stroke Center Alliance: a national effort to improve healthcare quality for acute stroke and transient ischaemic attack: rationale, design and preliminary findings.. 3:256-262. 2018
- Risk factors associated with 90-day recurrent stroke in patients on dual antiplatelet therapy for minor stroke or high-risk TIA: a subgroup analysis of the CHANCE trial.. 2:176-183. 2017